Novonix COO Sells 2.7M Performance‑Right Shares, Signals Equity‑Structure Overhaul Amid 59% Market Cap Decline
Novonix insider sales cut performance‑rights, streamlining equity and easing dilution risk—find out how this reshapes investor confidence.
3 minutes to read









